Hizentra (CSL Behring AG)


Welcome to the PulseAid listing for the Hizentra drug offered from CSL Behring AG. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: CSL Behring AG
NON-PROPRIETARY NAME: HUMAN IMMUNOGLOBULIN G
SUBSTANCE NAME: HUMAN IMMUNOGLOBULIN G
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2011-10-03
END MARKETING DATE: 0000-00-00


Hizentra PLASMA DERIVATIVE Details:

Item DescriptionHizentra from CSL Behring AG
LABELER NAME: CSL Behring AG
DEA SCHEDULE:
ACTIVE STRENGTH: 0.2(g/mL)
START MARKETING DATE: 2011-10-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44206-451_414ab6b7-15a9-4b09-9715-82cef5cb78cf
PRODUCT NDC: 44206-451
APPLICATION NUMBER: BLA125350

Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aptevo BioTherapeutics LLCWINRHO
Baxalta US Inc.GAMMAGARD Liquid
Bio Products Laboratory LimitedGammaplex
Biotest Pharmaceuticals CorporationBIVIGAM
Cangene BioPharma, LLCWINRHO
CSL Behring AGCarimune
GRIFOLS USA, LLCFlebogamma
KEDRION BIOPHARMA, INC.GAMMAKED
Octapharma ABOctagam Immune Globulin (Human)
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.Octagam Immune Globulin (Human)
Octapharma USA IncOctagam Immune Globulin (Human)